miR-132 level is also correlated with insoluble tau as well as cognitive impairment in humans, indicating the important role of miR-132/212 in regulating tau pathology in both mice and humans, thereby providing new alternatives for the development of new therapeutic agents. This evidence concerns the gene MAPT and Cognitive impairment.